Last reviewed · How we verify
NCT03411096
Quadratus Lumborum Block : Local Anesthesia Versus Placebo
NA trial testing Quadratus lumborum block using ropivacaine in Loop Ileostomy in 57 participants. Completed in 31 December 2024.
31 December 2024
Quick facts
| Lead sponsor | Kyungpook National University Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 57 |
| Start date | 8 April 2020 |
| Primary completion | 31 December 2024 |
| Estimated completion | 31 December 2024 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- Quadratus lumborum block using ropivacaine
- Quadratus lumborum block with normal saline
Conditions studied
- Loop Ileostomy — all drugs for Loop Ileostomy →
- Colorectal Disorders — all drugs for Colorectal Disorders →
Sponsor
Kyungpook National University Hospital
Who can join
Adults 20 to 75, any sex, with Loop Ileostomy or Colorectal Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Opioid analgesics have many side effects. Quadratus lumborum (QL) block is one kind of regional nerve block that can reduce the side effects of opioid analgesics. The investigators hypothesize that QL block with local analgesics (ropivacaine) can significantly reduce pain intensity in comparison with placebo.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Quadratus lumborum block for postoperative pain management in patients undergoing ileostomy closure: a prospective, randomized controlled trial.
Kang SJ, Park SY, Park JS, Yeo J. · · 2026 · PMID 41416367 · DOI 10.12701/jyms.2026.43.5
Verify or expand the search:
- PubMed search for NCT03411096
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Loop Ileostomy
Currently open trials in the same condition.
- NCT03720262 — Prevention of Hernia After Loop Ileostomy Reversal · Phase 2, PHASE3 · recruiting
Other Kyungpook National University Hospital trials
Trials by the same sponsor.
- NCT07265817 — Fecal Microbiota Transplantation for Decolonization of Multidrug-resistant Microorganisms · NA · not yet recruiting
- NCT06215040 — The Treatment Effect for Asymptomatic Common Bile Duct Stone · recruiting
- NCT05849324 — Intravascular Injection Rate During Lumbar Transforaminal Epidural Block Using Bent or Straight Needles · NA · unknown
- NCT05083026 — Neutralizing Antibody Level After COVID-19 Vaccination · unknown
- NCT05046054 — The Effect of Transcutaneous Electrical Nerve Stimulation on Pain During Propofol Injection · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03411096 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kyungpook National University Hospital
- Last refreshed: 6 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03411096.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing